Treatment of Atrial Tachycardia

Initial Assessment and Treatment

• The American Heart Association recommends immediate synchronized cardioversion for patients with atrial tachycardia who show signs of hemodynamic compromise 1, 2
• Cardioversion for atrial flutter can be successful at lower energy levels than for atrial fibrillation 2
• Appropriate anticoagulation considerations should be addressed prior to cardioversion when possible 3

Pharmacological Rate Control

• The American College of Cardiology recommends intravenous or oral beta blockers (metoprolol, esmolol, propranolol) for acute rate control in hemodynamically stable patients 1, 4, 5
• Calcium channel blockers (diltiazem, verapamil) are equally effective first-line agents for acute rate control 1, 2
• Intravenous diltiazem is the preferred calcium channel blocker due to its safety and efficacy profile 2

Rhythm Control Strategies

• Oral dofetilide or intravenous ibutilide are effective for acute pharmacological cardioversion 1, 2
• Amiodarone can be used for chemical cardioversion but is less effective than other agents 6, 7
• Elective synchronized cardioversion is indicated in stable patients when pursuing a rhythm-control strategy 2
• Cardioversion should be performed with appropriate anticoagulation based on duration of arrhythmia 3, 4

Long-term Management and Common Pitfalls

• For patients with recurrent atrial tachycardia, long-term antiarrhythmic therapy may be necessary 4
• Failing to recognize hemodynamic instability requiring immediate cardioversion 3
• Using verapamil or diltiazem in patients with pre-excitation, which can precipitate ventricular fibrillation 2, 3